eLetters

218 e-Letters

published between 2003 and 2006

  • Take the "pain" out? Cardiac event symptoms
    Darrell J Warrington

    Dear Editor,

    Re: Perry et al: Congratulations on your study. I have 20 years experience interviewing and assessing cardiac patients post AMI / PTCA and post CAGS and for a few years now have included a brief question at the cardiac rehabilitation entry assessment on the 'description' of the symptoms that caused the person to seek medical attention in the first instance.

    While many experience 'typical text book...

    Show More
  • A proposal for eplerenone in aortic stenosis
    Oscar, M Jolobe

    Dear Editor,

    For the sake of completeness, the thesis that the renin-angiotensin- aldosterone system (RAAS) might have a role in the pathogenesis of aortic stenosis[1], also requires a recognition that angiotensin converting enzyme(ACE)inhibitor therapy[2] might, on its own, be insufficient to retard progression of this disorder, and that a cardioprotective component specifically targeting aldosterone blockade by co...

    Show More
  • But the "new" cardiovascular risk factors?
    Ioan A Gutiu

    Dear Editor,

    The Rosengren’s et al. work is interesting by the great number of cases and by the accuracy of analysis.[1] However, we must mention that this study is reffering only to so-called “traditional” cardiovascular risk factors such as smoking, dyslipidaemia, diabetes, arterial hypertension, obesity. In actual phase of knowledge in the field of cardiovascular risk factors we need to analyze the other risk f...

    Show More
  • Clarification of QTc formulae
    Douglas J Ramseth

    Dear Editor,

    In the methods section, the formula for the Bazett correction should be indicated as QTc = QT/(RR ^ 0.5) with RR in seconds and the Fridericia correction formula should be indicated as QTc = QT/(RR ^ 0.333) with the RR in seconds. This would more clearly indicate the square root and cube root calculations used and also the relationship between the 2 corrections.

  • Paced patients: variables influencing cognitive impairment
    Francesco Corea

    Dear Editor

    The mechanisms underlying chronic cerebral damage in cardiological patients, as well as the risks of interventional procedures on older subjects is still debated. Gribbin work presents interesting data regarding the possible influence of cardiac pacing on cognitive impairment in older patients. The study, conducted using a single well designed prospective neuropsychological protocol, demonstrated a trend...

    Show More
  • Unilateral Pulmonary Edema
    Yoshio Misawa

    Dear Editor

    I read with great interest a paper by TomcsaáLnyi J and associates. [1] They presented a case of ischemic heart failure with unilateral pulmonary edema and hypothesized that a large eccentric mitral regurgitation jet reaching the left pulmonary veins caused the pulmonary edema. The paper is informative and shows convincing images.

    We have also have experienced a similarly unique case with unilate...

    Show More
  • ACE inhibitor can be the drug of choice in hypertension with aortic stenosis
    Alok K Singh
    Dear Editor

    I have reviewed the article carefully. As the author himself states an ACE inhibitor considered as a contraindication in aortic stenosis. There are certain limitations with the study, which I will like to point out:

    1. The samle size of the study is too small.
    2. Study is single blinded.
    3. What other drug pateint is taking not specified.
    4. Most of t...

    Show More
  • Use of antiplatelet therapy and antithrombin therapy may reduce the reintervention in stable angina
    Alok Kumar Singh
    Dear Editor

    I have read the article by T Nageh et al. They concluded that in patients with chronic ischemiuc heart disease who subjected to the PCI, developed the periprocedural increase in the cTROP-I in 30%, among these 18% required reintervention.

    It is not clear in the study whether patients presenting with periprocedural increase in enzyme were considered for aggressive antiplatelet therapy, they might required...

    Show More
  • Patients who complain of headaches afler sublingual nitroglycerin usually have no coronary disease
    Tsung O. Cheng

    Dear Editor,

    It is indeed very gratifying to read the report by Hsi et al.[1] that sublingual nitroglycerin (NTG) administration causes significantly more frequent headaches in patients with normal or minimally diseased coronary arteries than in patients with significant coronary artery disease (CAD). Over the years I have always felt that patients with chest pain who complained of significant headaches following s...

    Show More
  • Author's reply
    Martyn Thomas

    Dear Editor,

    I have read the letter from Professor Walley and colleagues with interest. I have no desire to restate my editorial but would have the following comments.

    Comments such as “data is virtually complete”, “only two patients underwent a second revascularisation in another north-west NHS hospital” and the low diabetes rates “are probably due to ethnicity differences” reflect all the problems of a...

    Show More

Pages